Skip to content

Open nowPosted 28 hours ago

MSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)

EURES job mobility portal314,718 open roles

Where
Groot-Amsterdam, Netherlands
Get the CV for this job

From $25 per CV, paid once. No subscription.

Your applicationOpen nowMSCA-DN PhD in lipid nanoparticle gene therapy for leukodystrophies (London, UK)EURES job mobility portal · Groot-Amsterdam, Netherlands
  1. YouYes, apply to this one.

  2. CV RocketCV written for this posting.

  3. 25 readersRecruiter, hiring manager, skeptic. Round after round.

  4. CV RocketApplied on EURES job mobility portal's own form.

The reply lands in your private mailbox

3×more interviews than doing it yourself with ChatGPT.

The clock on this job

Early applications get read.

7.8% of postings close within 7 days. Measured by our own scanner across the market.

Share of postings closed within
  1. 1.7%1 day
  2. 3.5%3 days
  3. 7.8%7 days
  4. 14.6%14 days
  5. 34.1%30 days
This job: posted 28 hours ago

The posting

Would you like to contribute to the development of new gene therapies for rare neurological diseases? Work on lipid nanoparticle-based therapies and help bring promising approaches closer to clinical application. POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's white matter. The network aims to strengthen the full translational pathway, from understanding disease mechanisms and developing disease models to preclinical therapy testing, clinical readiness and patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects of therapy development. The network will train a cohort of doctoral candidates in an international and interdisciplinary environment, combining academic research, industry-based preclinical development, secondments, network-wide training and transferable-skills development. PhD project For this position, University College London (UCL) is the recruiting organisation. You will be employed by UCL and embedded in the POLARIS consortium. Your academic supervision and disease-specific expertise will be provided by Professor Ahad A. Rahim (UCL School of Pharmacy), Professor Stephen Hart and Dr Julien Baruteau (UCL Great Ormond Street Institute of Child Health). Your PhD project focuses on the in vitro and in vivo preclinical assessment of genetic therapies for leukodystrophies. You will investigate lipid nanoparticle (LNP)-based approaches for delivering therapeutic nucleic acids, such as mRNA, in cellular and animal models. The research follows a translational pathway towards clinical application. You will investigate the functionality, biodistribution and cellular tropism of LNP-mRNA deliver

systems and evaluate their therapeutic efficacy in mouse models of leukodystrophies. A planned secondment at the University of York will provide experience of working with patient-family organisations and exposure to additional disease models. As a doctoral candidate, you will work across different stages of the preclinical research process. Your activities include: Testing the functionality of LNP-mRNA delivery systems in vitro. Analysing the biodistribution of delivery systems in the brain and peripheral tissues and investigating cellular tropism following different administration routes in mice. Conducting a preclinical study using the most promising LNP-mRNA delivery system and administration route in mouse models of leukodystrophies. Evaluating therapeutic efficacy using neuropathology, lifespan, locomotor and behavioural studies. Working with translational research supervisors and POLARIS partners to move promising approaches towards clinical application. We are looking for a candidate with a Master's degree in life sciences and relevant research experience. You bring the following: Experience with molecular technologies, neuroscience and in vivo mouse studies, gained through internships, thesis work or research projects. A strong interest in translational neuroscience, rare disease research and the development of genetic therapies. Experience with LNPs and animal models of neurological disease is an advantage. An accurate and reproducible approach to research, with strong attention to detail and the ability to plan and organise complex experimental work. Good analytical, communication and collaboration skills and the ability to work effectively in an interdisciplinary and international environment. Fluency in spoken and written English is essential for this international research environment. Eligibility criteria Important, strict eligibility criteria according to MARIE SKLODOWSKA CURIE programs apply to applicants: You must not already hold a doctoral

From $25, paid onceGet the CV for this job

What happens when you press

One press. We do the rest.

  1. A CV for this posting

    Written against EURES job mobility portal's own wording, from every piece of relevant proof in your profile.

  2. 25 readers review it

    Recruiter, hiring manager, skeptic and more read every draft, round after round. You get the best round.

    The review screen in CV Rocket: how each CV was read, round by round.
  3. We apply on EURES job mobility portal's form

    Our application engine gets through the hardest forms there are. Where a question needs you, AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

    An application in CV Rocket: every answer filled in on the employer's form.
  4. Every reply, sorted

    EURES job mobility portal's answer lands in your private mailbox, and we classify it on arrival: interview, question, rejection.

    The CV Rocket inbox: each employer reply classified as an interview, an action or a rejection.
  5. Reply with AI

    AI helps you write the email, checks it and sends it. We show you whether the recruiter read it.

  6. The interview in your calendar

    Full integration with your calendar. The invitation goes straight in.

    An interview invitation in the CV Rocket inbox, added to the candidate's calendar.
Get the CV for this job

From $25 per CV, paid once. No subscription.

Why it works

3×

more interviews than doing it yourself with ChatGPT.

ChatGPT writes a CV and never learns what happened to it. We see every reply. For each CV we know:

  • How it was written, and how the review scored it
  • When we applied, and how long after the posting went up
  • Which posting, which company, which city
  • Who got the interview, and who heard nothing

That is how we know which CVs get called.

Get the CV for this job

From $25 per CV, paid once. No subscription.

The numbers game

More applications. More interviews.

Every application goes out with its own CV, written for that posting and paid once. Send enough of them and the law of large numbers finds you the job.

By hand5–10
With CV Rocket100
applications a day

Before you press

Straight answers

Get the CV for this job

From $25 per CV, paid once. No subscription.

What if my background isn't good enough?

We make the most of the background you have. The CV uses every piece of relevant proof your profile holds, and one of the 25 readers reads your whole profile and flags what the CV left out.

Do you really apply for me?

Yes, on the employer's own form, the hardest ones included. Where a question needs you, you answer it right there and AI suggests the best answer. Don't want us applying from our IP addresses? Use our Chrome extension: we apply straight from your own browser.

Is it a subscription?

No. You pay once per CV, from $25. Every application goes out with its own CV, written for that posting.

One job. One CV.
Paid once.

Pick the posting you want. We write for it, apply for you and catch the reply.

Get the CV for this job

From $25 per CV, paid once. No subscription.